2019-2023 France Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Publisher Name :
Date: 05-Dec-2018
No. of pages: 1125

This new 1,125-page report from LeadingMarketResearch.com contains 58 tables, and presents comprehensive analysis of the French molecular diagnostics market, including:

  • Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Ten-year test volume and reagent sales forecasts for the following categories:
   

-  Infectious Diseases

   

-  Genetic Diseases

   

-  Cancer

   

-  Paternity Testing/HLA Typing

   

-  Forensic Testing

  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.
  • Contains 1,125 pages and 58 tables

    2019-2023 France Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

    Table of Contents

    I. Introduction
    II. Major Product Development Opportunities
    A. Instrumentation
    B. Reagent Kits and Test Systems/panels
    C. Computers, Software and Automation
    D. Auxiliary Products
    III. Design Criteria for Decentralized Testing Products
    IV. Alternative Market Penetration Strategies A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies For Decentralized Testing
    Markets
    V. Potential Market Entry Barriers and Risks
    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge And Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges
    VI. Market and Technology Review
    A. DNA Sequencing
    1. Introduction
    2. Sequencing Methods
    3. Autoradiography
    4. The Human Genome Project
    5. Sequencing Automation
    6. Image Scanners
    7. Fluorescent Detection
    8. Gene Profiling
    9. Gene Expression
    10. Polymorphism Screening
    11. Protein Interaction Networks
    B. DNA and RNA Probe Technologies
    1. Basic Principles
    2. Probe Preparation
    3. The DNA Probe Test
    4. Test Formats
    5. Labeling Techniques
    6. Amplification Methods
    C. Detection Technologies
    1. Radioactive Methods
    a. Overview
    b. Major Isotopes
    - P-32
    - S-35
    - H-3
    - I-125
    2. Non-Isotopic Methods
    a. Enzymatic Labels
    b. Chemical Labeling
    - Indirect Chemical Labeling
    - Direct Chemical Labeling
    c. Fluorescence
    d. Chemiluminescence
    e. Electrical Conductivity
    D. Molecular Diagnostic Instrumentation Review
    1. Abbott LCx
    2. Beckman Coulter/Biomek FK
    3. BD Viper System with XTR Technology
    4. BD Innova
    5. Becton Dickinson SDA
    6. bioMerieux NucliSENS easyMAG
    7. bioMerieux NucliSENS easyQ and MiniMAG
    8. Bio-Rad GeneScope
    9. Cepheid GeneXpert
    10. Curetis Unyvero
    11. GenMark Dx eSensor XT-8
    12. Hologic/Gen-Probe Panther
    13. Hologic/Gen-Probe Tigris/DTS
    14. HTG Molecular Edge
    15. Life Technologies QuantStudio Dx
    16. Qiagen QIAsymphony RGQ
    17. Roche Cobas Amplicor
    18. Roche Cobas TaqMan 48
    19. Roche Cobas TaqMan
    20. Roche Cobas TaqMan AmpliPrep
    21. Roche LighCycler 480
    22. Roche Cobas 4800
    23. Roche Cobas s 201
    24. Siemens Versant
    25. Tecan LS Series
    E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
    - Liquid Transportation and Mixing
    - Separation
    - Reaction
    - Detection
    F. Pharmacogenomics
    G. Major Applications
    1. Microbiology/Infectious Diseases
    a. Overview
    b. Major Infectious Diseases
    ° AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
    ° Adenovirus
    ° Aeromonas
    ° Anthrax/Bacillus Anthracis
    ° Arboviruses
    ° Babesiosis
    ° Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
    ° Blastocystis Hominis
    ° Brucella
    ° Campylobacter
    ° Candida
    ° Chagas Disease
    ° Chancroid
    ° Chlamydia
    ° Clostridium Difficile
    ° Coronaviruses
    ° Coxsackieviruses
    ° Creutzfeldt-Jakob's Disease
    ° Cryptosporidium Parvum
    ° Cyclospora Cayetanensis
    ° Cytomegalovirus
    ° Ebola Virus
    ° E. Coli
    ° EchoVirus
    ° Encephalitis
    ° Enteroviruses
    ° Epstein-Barr Virus
    ° Giardia Lamblia
    ° Gonorrhea
    ° Granuloma Inguinale
    ° Hantavirus
    ° Helicobacter Pylori
    ° Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
    ° Herpes Simplex Virus
    ° Human Herpes Virus-6 (HHV-6)
    ° Influenza Viruses
    ° Legionella
    ° Lyme Disease
    ° Lymphogranuloma Venereum (LGV)
    ° Malaria
    ° Measles (Rubeola)
    ° Meningitis
    ° Microsporidium
    ° Mononucleosis
    ° Mumps
    ° Mycoplasma
    ° Papillomaviruses
    ° Parvovirus B19
    ° Pneumonia
    ° Polyomaviruses
    ° Pseudomonas Aeruginosa
    ° Rabies
    ° Respiratory Syncytial Virus (RSV)
    ° Rhinoviruses
    ° Rotavirus
    ° Rubella
    ° Salmonellosis
    ° Septicemia
    ° Shigellosis
    ° Staphylococcus Aureus
    ° Streptococci
    ° Syphilis
    ° Toxoplasmosis
    ° Trichomonas Vaginalis
    ° Tuberculosis
    ° Vibrio
    ° West Nile Virus
    ° Yersina
    2. Cancer Testing
    a. Overview
    b. Major Cancer Types
    * Prostate
    * Lung
    * Colon and Rectum
    * Breast
    * Skin
    * Uterine
    * Leukemia
    * Oral
    c. Oncogenes
    - Abl/abl-bcr
    - AIB1
    - BCL-2
    - BRCA1
    - CD44
    - C-fos
    - C-myb
    - C-myc
    - CYP17
    - Erb-B
    - HPC1
    - N-myc
    - P40
    - P51
    - P53
    - PIK3CA
    - PTI-1
    - Ras
    - Reg
    - Sis
    - Src
    3. Genetic Diseases
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
    * Achondroplasia
    * Autosomal Dominant Polycystic Kidney
    Disease
    * Cancer
    * Cosmetogenomics
    * Cystic Fibrosis
    * Down's Syndrome
    * Duchenne and Becker Muscular Dystrophy
    * Factor V (Leiden)
    * Factor IX Deficiency
    * Fragile X Syndrome
    * Heart Disease
    * Hemochomatosis
    * Hemophilia
    * Huntington's Disease
    * Maternal-Fetal Incompatibility
    * Multiple Endocrine Neoplasia
    * Phenylketonuria (PKU)
    * Polycystic Kidney Disease (PKD)
    * Prenatal Screening
    * Retinitis Pigmentosa
    * Retinoblastoma
    * Sickle Cell Anemia
    * Spinal Muscular Atrophy
    * Vitamin B12 Metabolism
    i. Social Issues and Concerns
    4. Forensic Testing
    a. Overview
    b. Multilocus and Single Locus Probes
    * Multilocus Probes
    * Single Locus Probes
    * PCR and RFLP
    c. The FBI
    d. DNA Profile Data Banks
    * U.S.A.
    * U.K.
    e. Judicial Implementation
    f. Major Crime Categories
    g. Factors Contributing to the DNA Probe
    Market Expansion
    * Technology Availability
    * Use of Hair as Evidence
    h. Wildlife Forensics
    5. Paternity Testing/HLA Typing
    6. Other Applications
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other
    H. Competing/complementing
    1. Monoclonal Antibodies/Immunoassays
    2. RNA Probes
    3. Two-Dimensional Electrophoresis
    4. Flow Cytometry
    VII. France Molecular Diagnostics Market
    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
    VIII. Competitive Assessments
    - Abbott
    - Affymetrix
    - Agilent Technologies
    - Applied Gene Technologies
    - Arca Biopharma
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - Biokit
    - bioMerieux
    - Bio-Rad
    - Biotest
    - Cepheid
    - CellMark Forensics/LabCorp
    - Decode Genetics
    - Diadexus
    - Eiken
    - Elitech Group
    - Enzo
    - Exact Sciences
    - Fujirebio
    - Grifols
    - Hologic/Gen-Probe
    - Illumina
    - Kreatech/Leica
    - Li-Cor Biosciences
    - Monogram Biosciences/LabCorp
    - Myriad Genetics
    - Ortho-Clinical Diagnostics
    - Perkin Elmer/Caliper
    - Proteome Sciences
    - Qiagen
    - Roche
    - Scienion
    - Sequenom
    - Shimadzu
    - Siemens
    - Sierra Molecular
    - Takara Bio
    - Tecan Group
    - Thermo Fisher
    XIII. Appendix: Major Universities and Research Centers
    Developing Molecular Diagnostic Technologies

    List of Tables

    Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Malaria Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
    Oncogenes Potential Application in Cancer Diagnosis
    Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
    Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
    France Molecular Diagnostics Test Volume And Sales By Major Application
    France Laboratories Performing DNA Sequencing By Market Segment
    France Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
    France Molecular Diagnostics Test Volume By Major Application
    France Major Infectious Disease Test Volume by Assay
    France Major Infectious Disease Test Volume by Method
    France Molecular Diagnostics Market By Major Application
    France Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
    France Major Infectious Disease Diagnostics Market by Assay
    France AIDS Testing Market Estimated Sales by Major Supplier
    France Adenovirus Testing Market Estimated Sales by Major Supplier
    France Chlamydia/Gonorrhea Testing Market Estimated Sales by Major Supplier
    France CMV Testing Market Estimated Sales by Major Supplier
    France Hepatitis C Testing Market Estimated Sales by Major Supplier
    France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
    France Herpes Testing Market Estimated Sales by Major Supplier
    France Influenza Testing Market Estimated Sales by Major Supplier
    France Meningitis Testing Market Estimated Sales by Major Supplier
    France Mycoplasma Testing Market Estimated Sales by Major Supplier
    France RSV Testing Market Estimated Sales by Major Supplier
    France Shigella Testing Market Estimated Sales by Major Supplier
  • Molecular Diagnostics Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 400
    Molecular Diagnostics Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the molecular diagnostics deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of molecular diagnostics deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics deals. These deals tend to be multicomponent, s......
  • Global Molecular Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 31-Oct-2023        Price: US 3380 Onwards        Pages: 120
    Market Overview of Global Molecular Diagnostic market: According to our latest research, the global Molecular Diagnostic market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Molecular D......
  • Global Core Clinical Molecular Diagnostics Market (2023 Edition): Analysis By Technology (ISH, PCR, Sequencing, Others), By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Others), By Region, By Country: Market Insights and Forecast (2019-2029)
    Published: 01-Oct-2023        Price: US 2450 Onwards        Pages: 220
    Executive Summary Azoth Analytics has released a research report titled "Global Core Clinical Molecular Diagnostics Market (2023 Edition)" which provides a complete analysis of the Global Core Clinical Molecular Diagnostics industry in terms of market segmentation By Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Others) and By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Other Applications) for the historical p......
  • Global Molecular Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Sep-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Molecular Diagnostics market: According to our latest research, the global Molecular Diagnostics market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Molecular diagnosis refers to applying molecular biology methods to detect changes in the structure or expression level of genet......
  • Global Molecular Diagnostics in Infectious Disease Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 31-Aug-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Molecular Diagnostics in Infectious Disease Testing market: According to our latest research, the global Molecular Diagnostics in Infectious Disease Testing market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostics in Infectious Disease Testing market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time spa......
  • Global Molecular Diagnostics Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 114
    Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes. Market Analysis and Insights: Global Molecular Diagnost......
  • Global Molecular Diagnostics Market 2023
    Published: 13-Aug-2023        Price: US 2450 Onwards        Pages: 89
    Description According to the latest data, the market size of the global satellite imaging for agriculture sector is expected to rise by USD 234.5 million with a CAGR of 6.26% by the end of 2029. The implementation of satellite imaging in agriculture involves utilizing satellites to capture high-resolution images of agricultural land. These images offer valuable data and insights that can be leveraged to improve agricultural systems and enhance farming practices. One of the key......
  • Global Molecular Diagnostics in Infectious Disease Testing Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 22-Jun-2023        Price: US 3260 Onwards        Pages: 129
    The Molecular Diagnostics in Infectious Disease Testing market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Molecular Diagnostics in Infectious Disease Testing industry, and breaks down according to the type, application, and consumption area of Molecular Diagnostics in Infectious Disease Testing. The report also introduces pla......
  • Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Instruments, Software), Application (Respiratory Diseases, HAIs, Cancer, STDs, Hepatitis), Technology (RT-PCR, INAAT), End User (Clinics, Hospitals, ICUs) & Region - Global Forecast to 2028
    Published: 14-Jun-2023        Price: US 4950 Onwards        Pages: 212
    “Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market” The global point-of-care molecular diagnostics market size is projected to reach USD 3.4 billion by 2028 from USD 2.0 billion in 2023, at a CAGR of 10.6% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious dise......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs